Prenetics Global Ltd·4

Jun 16, 8:38 AM ET

VANDERVEEN DAVID 4

Research Summary

AI-generated summary

Updated

Prenetics (PRE) Director David Vanderveen Receives 6,944 Shares

What Happened David Vanderveen, a director of Prenetics Global Ltd (PRE), had 6,944 Class A ordinary shares issued and delivered on June 15, 2026 upon settlement of vested restricted stock units (RSUs). The Form 4 reports an "exercise/conversion of derivative (M)" for 6,944 shares acquired at $0.00 and a related report of 8,681 shares disposed at $0.00. Footnotes state that 6,944 RSUs vested and were settled and any remaining unvested RSUs were forfeited in connection with Vanderveen’s termination of service.

Key Details

  • Transaction date: June 15, 2026; Form 4 filed June 16, 2026 (timely filing).
  • Acquired: 6,944 shares via RSU settlement at $0.00 (no cash exchanged).
  • Disposed/cancelled: 8,681 (reported as a derivative disposition at $0.00); footnotes indicate unvested RSUs were forfeited upon termination.
  • Shares owned after transaction: not specified in the provided filing details.
  • Footnotes: F1/F2 confirm these were RSUs granted under the Issuer’s 2022 Share Incentive Plan; vested RSUs were settled and remaining unvested RSUs forfeited.

Context RSUs are contingent awards that convert into shares when they vest; this filing reflects the settlement of vested RSUs (not an open-market buy or sale). No cash changed hands for the vested shares; the reported disposition appears tied to forfeiture of unvested RSUs upon Vanderveen’s departure, which is a routine administrative result of termination rather than a market-driven sale.